Prolonged atherosclerotic lesion of internal carotid artery: six types of reconstruction. Multiple-center study

Carotid Enadrterectomy for Thrombosis of the Internal Carotid Artery in Patients With COVID-19

“…Speaking about the choice of the type of carotid endarterectomy, it is necessary to note the importance of the glomus-sparing eversion technique. The rejection of the classical technique with patch implantation is justified by the reduction in the duration of the operation and the risk of restenosis in the mid-term follow-up period [ 22 , 23 ]. Preservation of the carotid glomus during carotid endarterectomy made it possible to control blood pressure at the level of normotonia in the early postoperative period.…”

Long-term outcomes of eversion and conventional carotid endarterectomy: A multicenter clinical trial

“…For >50 years, both eversion (ECEA) and conventional carotid endarterectomy (CCEA) have been the 'gold standard' of cerebral revascularization, a surgical intervention aimed on treatment of internal carotid artery (ICA) stenosis [1][2][3][4][5] . ECEA is performed by cutting off the ICA from the bifurcation with the further endarterectomy after artery eversion [6,7] . In contrast, CCEA implies a longitudinal arteriotomy from the common carotid artery to the ICA [8,9] .…”

Effects of different types of carotid endarterectomy on the course of resistant arterial hypertension

“…[1][2][3][4][5] The typical contingent of patients undergoing this intervention most often suffers from coronary heart disease, diabetes mellitus, multifocal atherosclerosis (MFA), chronic renal insufficiency and other comorbid conditions. [6][7][8][9][10] At the same time, the importance of hemodynamically significant stenosis correction may exceed the necessity for full compensation of concomitant pathology (poorly controlled diabetes, uncompensated arterial hypertension), if it comes to, for example, subocclusion or unstable atherosclerotic plaque in the internal carotid artery (ICA). 2,5,[8][9][10] A separate question raises the justification of CEE in patients with resistant arterial hypertension (RAH), the number of which, according to a number of studies, reaches 40% of the total patient sample.…”